Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
1,213 Last 12 Months
Buy Ratings
1,051 Last 12 Months
Sell Ratings
4 Last 12 Months
Companies Covered
414 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Paylocity Holding Corporation stock logo
PCTY
Paylocity
$177.19
-0.3%
10/23/2026Boost Price Target$180.00 ➝ $200.00BuyView details for Guggenheim rating of Paylocity (NASDAQ:PCTY) on 10/23/2026
AppFolio, Inc. stock logo
APPF
AppFolio
$210.62
-3.1%
10/23/2026Boost Price Target$232.00 ➝ $239.00BuyView details for Guggenheim rating of AppFolio (NASDAQ:APPF) on 10/23/2026
ServiceNow, Inc. stock logo
NOW
ServiceNow
$159.30
+1.5%
10/23/2026Reiterated Rating$125.00 ➝ $175.00BuyView details for Guggenheim rating of ServiceNow (NYSE:NOW) on 10/23/2026
Automatic Data Processing, Inc. stock logo
ADP
Automatic Data Processing
$304.16
-1.2%
10/23/2026Boost Price Target$300.00 ➝ $340.00BuyView details for Guggenheim rating of Automatic Data Processing (NASDAQ:ADP) on 10/23/2026
argenex SE stock logo
ARGX
argenex
$873.71
-0.2%
10/23/2026Lower Price Target$1,185.00 ➝ $1,120.00BuyView details for Guggenheim rating of argenex (NASDAQ:ARGX) on 10/23/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$6.93
-7.0%
10/23/2026Reiterated RatingBuy ➝ NeutralView details for Guggenheim rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/23/2026
Paycom Software, Inc. stock logo
PAYC
Paycom Software
$274.64
+0.7%
10/23/2026Boost Price Target$225.00 ➝ $300.00BuyView details for Guggenheim rating of Paycom Software (NYSE:PAYC) on 10/23/2026
Spotify Technology stock logo
SPOT
Spotify Technology
$583.84
+0.0%
10/23/2026Boost Price Target$575.00 ➝ $650.00BuyView details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 10/23/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
$440.05
-1.2%
10/22/2026Boost Price Target$460.00 ➝ $485.00BuyView details for Guggenheim rating of Elevance Health (NYSE:ELV) on 10/22/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$642.62
-1.0%
10/22/2026Reiterated Rating$850.00BuyView details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/22/2026
NIKE, Inc. stock logo
NKE
NIKE
$37.32
-2.6%
10/22/2026Reiterated Rating$50.00BuyView details for Guggenheim rating of NIKE (NYSE:NKE) on 10/22/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$524.51
+0.7%
10/21/2026Reiterated Rating$586.00BuyView details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 10/21/2026
Northrop Grumman Corporation stock logo
NOC
Northrop Grumman
$551.38
-0.2%
10/21/2026Boost Price Target$612.00 ➝ $640.00BuyView details for Guggenheim rating of Northrop Grumman (NYSE:NOC) on 10/21/2026
GE Aerospace stock logo
GE
GE Aerospace
$285.76
-2.7%
10/21/2026 Set Price Target$380.00View details for Guggenheim rating of GE Aerospace (NYSE:GE) on 10/21/2026
Six Flags Entertainment Corporation stock logo
FUN
Six Flags Entertainment
$6.78
-6.3%
10/21/2026Lower Price Target$28.00 ➝ $17.00BuyView details for Guggenheim rating of Six Flags Entertainment (NYSE:FUN) on 10/21/2026
The Kroger Co. stock logo
KR
Kroger
$66.88
-1.5%
10/21/2026Reiterated Rating$66.00 ➝ $68.00BuyView details for Guggenheim rating of Kroger (NYSE:KR) on 10/21/2026
Novogen Limited stock logo
KZIA
Novogen
$7.81
-3.2%
10/21/2026Initiated Coverage$35.00BuyView details for Guggenheim rating of Novogen (NASDAQ:KZIA) on 10/21/2026
Netflix, Inc. stock logo
NFLX
Netflix
$65.85
-1.8%
10/21/2026Lower Price Target$80.00 ➝ $78.00BuyView details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/21/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$25.93
-2.3%
10/20/2026Boost Price Target$65.00 ➝ $70.00BuyView details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/20/2026
TKO Group Holdings, Inc. stock logo
TKO
TKO Group
$172.86
-2.7%
10/20/2026Lower Price Target$235.00 ➝ $228.00BuyView details for Guggenheim rating of TKO Group (NYSE:TKO) on 10/20/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$88.01
-2.5%
10/20/2026Reiterated Rating$175.00BuyView details for Guggenheim rating of Abivax (NASDAQ:ABVX) on 10/20/2026
Equinix, Inc. stock logo
EQIX
Equinix
$955.03
+0.3%
10/20/2026Reiterated Rating$1,235.00BuyView details for Guggenheim rating of Equinix (NASDAQ:EQIX) on 10/20/2026
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$227.61
+2.0%
10/19/2026Boost Price Target$165.00 ➝ $280.00BuyView details for Guggenheim rating of Atlassian (NASDAQ:TEAM) on 10/19/2026
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
$31.20
-3.1%
10/19/2026Boost Price Target$38.00 ➝ $44.00BuyView details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 10/19/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.40
-5.5%
10/19/2026DowngradeBuy ➝ NeutralView details for Guggenheim rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 10/19/2026
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$268.13
-0.9%
10/16/2026Boost Price Target$283.00 ➝ $307.00BuyView details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 10/16/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$66.53
-3.7%
10/16/2026Reiterated Rating$125.00BuyView details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 10/16/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$673.97
-0.4%
10/15/2026 Initiated CoverageBuyView details for Guggenheim rating of Thermo Fisher Scientific (NYSE:TMO) on 10/15/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$673.97
-0.4%
10/15/2026 Reiterated Rating$740.00BuyView details for Guggenheim rating of Thermo Fisher Scientific (NYSE:TMO) on 10/15/2026
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$65.11
-4.1%
10/15/2026Reiterated Rating$90.00BuyView details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 10/15/2026
DoorDash, Inc. stock logo
DASH
DoorDash
$179.38
-3.5%
10/14/2026Reiterated Rating$255.00BuyView details for Guggenheim rating of DoorDash (NASDAQ:DASH) on 10/14/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$642.62
-1.0%
10/14/2026Boost Price Target$700.00 ➝ $850.00BuyView details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/14/2026
Sphere Entertainment Co. stock logo
SPHR
Sphere Entertainment
$109.07
-2.3%
10/14/2026Lower Price Target$208.00 ➝ $180.00BuyView details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 10/14/2026
Amgen Inc. stock logo
AMGN
Amgen
$439.26
-1.8%
10/13/2026Lower Price Target$388.00 ➝ $378.00NeutralView details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 10/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
$30.04
-1.3%
10/13/2026Reiterated RatingBuyView details for Guggenheim rating of Pfizer (NYSE:PFE) on 10/13/2026
GE Vernova Inc. stock logo
GEV
GE Vernova
$814.37
-1.6%
10/13/2026Reiterated Rating$1,450.00BuyView details for Guggenheim rating of GE Vernova (NYSE:GEV) on 10/13/2026
Everpure, Inc. stock logo
P
Everpure
$123.33
+1.8%
10/12/2026Boost Price Target$150.00 ➝ $215.00BuyView details for Guggenheim rating of Everpure (NYSE:P) on 10/12/2026
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
$38.73
-1.8%
10/12/2026Reiterated RatingBuyView details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/12/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
$440.05
-1.2%
10/12/2026Boost Price Target$455.00 ➝ $460.00BuyView details for Guggenheim rating of Elevance Health (NYSE:ELV) on 10/12/2026
Ducommun Incorporated stock logo
DCO
Ducommun
$157.18
-1.8%
10/9/2026Initiated Coverage$246.00BuyView details for Guggenheim rating of Ducommun (NYSE:DCO) on 10/9/2026
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad)

A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel

See the ticker behind this Grand Canyon energy breakthrough now
AbbVie Inc. stock logo
ABBV
AbbVie
$285.66
+0.2%
10/9/2026Reiterated Rating$288.00BuyView details for Guggenheim rating of AbbVie (NYSE:ABBV) on 10/9/2026
Ducommun Incorporated stock logo
DCO
Ducommun
$157.18
-1.8%
10/9/2026Initiated Coverage$246.00BuyView details for Guggenheim rating of Ducommun (NYSE:DCO) on 10/9/2026
STUB stock logo
STUB
STUB
$5.84
-4.3%
10/9/2026Lower Price Target$11.00 ➝ $9.00BuyView details for Guggenheim rating of STUB (NYSE:STUB) on 10/9/2026
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$41.52
-1.0%
10/8/2026Reiterated RatingBuyView details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 10/8/2026
Centrus Energy Corp. stock logo
LEU
Centrus Energy
$102.38
-1.7%
10/8/2026Initiated Coverage$167.00BuyView details for Guggenheim rating of Centrus Energy (NYSE:LEU) on 10/8/2026
Centrus Energy Corp. stock logo
LEU
Centrus Energy
$102.38
-1.7%
10/8/2026Initiated Coverage$167.00BuyView details for Guggenheim rating of Centrus Energy (NYSE:LEU) on 10/8/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$21.00
+9.4%
10/7/2026Lower Price Target$45.00 ➝ $18.00BuyView details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 10/7/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$255.15
+7.3%
10/7/2026Boost Price Target$214.00 ➝ $254.00BuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 10/7/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$20.91
-0.1%
10/7/2026Lower Price Target$33.00 ➝ $30.00BuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/7/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$20.91
-0.1%
10/7/2026Lower Price Target$33.00 ➝ $30.00BuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/7/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$264.13
-1.3%
10/7/2026Reiterated Rating$287.00BuyView details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 10/7/2026
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
$38.73
-1.8%
10/6/2026Initiated Coverage$80.00BuyView details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/6/2026
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$142.70
-0.4%
10/6/2026Initiated Coverage$207.00BuyView details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/6/2026
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
$2.16
-8.9%
10/6/2026Initiated Coverage$7.00BuyView details for Guggenheim rating of Ovid Therapeutics (NASDAQ:OVID) on 10/6/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$25.93
-2.3%
10/6/2026Initiated Coverage$65.00BuyView details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/6/2026
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$35.34
-3.2%
10/6/2026Initiated Coverage$73.00BuyView details for Guggenheim rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/6/2026
Yum! Brands, Inc. stock logo
YUM
Yum! Brands
$149.75
-3.0%
10/6/2026Lower Price Target$180.00 ➝ $155.00BuyView details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 10/6/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$25.93
-2.3%
10/5/2026Initiated Coverage$65.00BuyView details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
$7.97
-3.4%
10/5/2026Initiated CoverageNeutralView details for Guggenheim rating of Maplight Therapeutics (NASDAQ:MPLT) on 10/5/2026
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
$38.73
-1.8%
10/5/2026Initiated Coverage$80.00BuyView details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/5/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$25.93
-2.3%
10/5/2026Initiated Coverage$65.00BuyView details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$43.79
+9.5%
10/5/2026Boost Price Target$45.00 ➝ $54.00BuyView details for Guggenheim rating of Genmab A/S (NASDAQ:GMAB) on 10/5/2026
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$60.43
-3.9%
10/5/2026Boost Price Target$116.00 ➝ $125.00BuyView details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 10/5/2026
McDonald's Corporation stock logo
MCD
McDonald's
$248.49
-1.6%
10/5/2026Lower Price Target$290.00 ➝ $250.00NeutralView details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/5/2026
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
$2.16
-8.9%
10/5/2026Initiated Coverage$7.00BuyView details for Guggenheim rating of Ovid Therapeutics (NASDAQ:OVID) on 10/5/2026
Yesway, Inc. stock logo
YSWY
Yesway
$24.64
+0.6%
10/5/2026Reiterated Rating$32.00BuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 10/5/2026
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$2.00
-0.5%
10/2/2026Lower Price Target$12.00 ➝ $5.00BuyView details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$9.58
-3.7%
10/2/2026Boost Price Target$25.00 ➝ $26.00BuyView details for Guggenheim rating of Sagimet Biosciences (NASDAQ:SGMT) on 10/2/2026
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
$48.50
-3.9%
10/2/2026Boost Price Target$88.00 ➝ $150.00BuyView details for Guggenheim rating of MBX Biosciences (NASDAQ:MBX) on 10/2/2026
NIKE, Inc. stock logo
NKE
NIKE
$37.32
-2.6%
10/2/2026Reiterated Rating$60.00 ➝ $50.00BuyView details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2026
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$2.00
-0.5%
10/2/2026Lower Price Target$12.00 ➝ $5.00BuyView details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026
Accenture PLC stock logo
ACN
Accenture
$249.42
-3.6%
10/2/2026Reiterated RatingNeutralView details for Guggenheim rating of Accenture (NYSE:ACN) on 10/2/2026
Waters Corporation stock logo
WAT
Waters
$453.42
-0.5%
10/1/2026Boost Price Target$440.00 ➝ $490.00BuyView details for Guggenheim rating of Waters (NYSE:WAT) on 10/1/2026
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$139.92
+3.3%
10/1/2026Boost Price Target$107.00 ➝ $212.00BuyView details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 10/1/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
$67.61
+6.0%
10/1/2026Boost Price Target$65.00 ➝ $92.00BuyView details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 10/1/2026
Natera, Inc. stock logo
NTRA
Natera
$403.95
+0.6%
10/1/2026Boost Price Target$360.00 ➝ $475.00BuyView details for Guggenheim rating of Natera (NASDAQ:NTRA) on 10/1/2026
Illumina, Inc. stock logo
ILMN
Illumina
$269.42
+0.0%
10/1/2026Boost Price Target$226.00 ➝ $305.00BuyView details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 10/1/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
$169.08
+3.8%
10/1/2026Boost Price Target$190.00 ➝ $200.00BuyView details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 10/1/2026
Danaher Corporation stock logo
DHR
Danaher
$230.36
+0.3%
10/1/2026Boost Price Target$200.00 ➝ $250.00BuyView details for Guggenheim rating of Danaher (NYSE:DHR) on 10/1/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
$17.98
+0.8%
10/1/2026Boost Price Target$16.00 ➝ $19.00BuyView details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 10/1/2026
Bruker Corporation stock logo
BRKR
Bruker
$57.59
+0.5%
10/1/2026Boost Price Target$70.00 ➝ $72.00BuyView details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 10/1/2026
Billiontoone, Inc. stock logo
BLLN
Billiontoone
$107.77
+2.0%
10/1/2026Boost Price Target$125.00 ➝ $128.00BuyView details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 10/1/2026
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$25.51
+4.5%
10/1/2026Boost Price Target$25.00 ➝ $32.00BuyView details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/1/2026
Netflix, Inc. stock logo
NFLX
Netflix
$65.85
-1.8%
10/1/2026Reiterated Rating$75.00 ➝ $80.00BuyView details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/1/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
$132.55
+4.3%
10/1/2026Boost Price Target$75.00 ➝ $155.00BuyView details for Guggenheim rating of GRAIL (NASDAQ:GRAL) on 10/1/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$56.15
-16.4%
10/1/2026Boost Price Target$74.00 ➝ $83.00BuyView details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 10/1/2026
DICK'S Sporting Goods, Inc. stock logo
DKS
DICK'S Sporting Goods
$144.62
-2.8%
9/30/2026 Reiterated RatingNeutralView details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 9/30/2026
Neogen Corporation stock logo
NEOG
Neogen
$12.19
+1.8%
9/30/2026Reiterated Rating$12.00 ➝ $14.00BuyView details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 9/30/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$26.87
-4.8%
9/30/2026Reiterated Rating$55.00BuyView details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 9/30/2026
BWX Technologies, Inc. stock logo
BWXT
BWX Technologies
$127.27
0.0%
9/30/2026Reiterated Rating$192.00BuyView details for Guggenheim rating of BWX Technologies (NYSE:BWXT) on 9/30/2026
Why tech stocks are dead (Ad)

AI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.tc pixel

Watch Porter Stansberry's broadcast to see which sector could lead next
MongoDB, Inc. stock logo
MDB
MongoDB
$371.09
+2.4%
9/29/2026Reiterated Rating$560.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 9/29/2026
AAR Corp. stock logo
AIR
AAR
$95.30
-1.4%
9/29/2026Reiterated RatingNeutralView details for Guggenheim rating of AAR (NYSE:AIR) on 9/29/2026
Warner Music Group Corp. stock logo
WMG
Warner Music Group
$30.86
-2.6%
9/29/2026Reiterated Rating$36.00BuyView details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 9/29/2026
Costco Wholesale Corporation stock logo
COST
Costco Wholesale
$1,003.32
-1.5%
9/28/2026 Reiterated RatingNeutralView details for Guggenheim rating of Costco Wholesale (NASDAQ:COST) on 9/28/2026
The Walt Disney Company stock logo
DIS
Walt Disney
$112.61
-0.5%
9/28/2026Reiterated Rating$120.00BuyView details for Guggenheim rating of Walt Disney (NYSE:DIS) on 9/28/2026
First Solar, Inc. stock logo
FSLR
First Solar
$171.99
+0.4%
9/28/2026Reiterated RatingBuyView details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 9/28/2026
Absci Corporation stock logo
ABSI
Absci
$9.18
-2.0%
9/28/2026Reiterated RatingBuyView details for Guggenheim rating of Absci (NASDAQ:ABSI) on 9/28/2026
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
$31.31
-6.3%
9/28/2026Initiated Coverage$70.00BuyView details for Guggenheim rating of Cyclerion Therapeutics (NASDAQ:KRSA) on 9/28/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$255.15
+7.3%
9/25/2026Reiterated RatingBuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 9/25/2026
Akamai Technologies, Inc. stock logo
AKAM
Akamai Technologies
$93.53
+2.6%
9/25/2026Boost Price Target$190.00 ➝ $225.00BuyView details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 9/25/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 405 companies across 11 sectors over the past 12 months, covered by 33 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Healthcare (44.9%), Consumer Discretionary (16.9%) and Technology (11.8%). The chart below shows how Guggenheim's 414 rated companies are distributed across all 11 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 345 companies. Recent upgrades to buy include Entera Bio, Editas Medicine, New York Times, Sensei Biotherapeutics and Hexcel.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Subbu Nambi and Michael Schmidt. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 39 analysts at Guggenheim.

Guggenheim has the deepest coverage in Healthcare (44.9% of rated companies), Consumer Discretionary (16.9% of rated companies), Technology (11.8% of rated companies), Industrials (10.9% of rated companies) and Communication Services (8.2% of rated companies).

Guggenheim issued 1,213 ratings over the last 12 months across 414 companies — an average of roughly 101 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.